These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33417692)

  • 1. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
    Younis A; Goldberger JJ; Kutyifa V; Zareba W; Polonsky B; Klein H; Aktas MK; Huang D; Daubert J; Estes M; Cannom D; McNitt S; Stein K; Goldenberg I
    Eur Heart J; 2021 May; 42(17):1676-1684. PubMed ID: 33417692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy.
    Dauw J; Martens P; Nijst P; Meekers E; Deferm S; Gruwez H; Rivero-Ayerza M; Van Herendael H; Pison L; Nuyens D; Dupont M; Mullens W
    Europace; 2022 Sep; 24(8):1276-1283. PubMed ID: 35352116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental Value of Right Ventricular Outflow Tract Diameter in Risk Assessment of Chronic Heart Failure Patients with Implantable Cardioverter Defibrillators: Development of RVOTD-ICD Benefit Score in Real-World Setting.
    Huang H; Deng Y; Cheng S; Yu Y; Liu X; Niu H; Chen X; Cai C; Gu M; Hua W
    Rev Cardiovasc Med; 2023 Sep; 24(9):269. PubMed ID: 39076385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
    Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
    JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing risk analysis of ventricular arrhythmia events in heart failure patients with moderately compromised renal dysfunction.
    Goldenberg I; Younis A; Aktas MK; McNitt S; Zareba W; Kutyifa V
    Europace; 2020 Sep; 22(9):1384-1390. PubMed ID: 32875313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction Efficiency of MADIT-ICD Benefit Score for Outcome in Asian Patients with Implantable Cardioverter-Defibrillator.
    Song K; Hu Y; Chen W; Hua W; Jin Z
    Int J Gen Med; 2022; 15():4409-4416. PubMed ID: 35502185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events.
    Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W
    Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure.
    Jędrzejczyk-Patej E; Mazurek M; Lazar M; Pruszkowska-Skrzep P; Sokal A; Kowalczyk J; Kowalski O; Kalarus Z; Lenarczyk R
    Kardiol Pol; 2023; 81(10):998-1005. PubMed ID: 37936556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin and Risk of Ventricular Tachyarrhythmia and Death in ICD Recipients.
    Ojo A; McNitt S; Polonsky B; Aktas MK; Rosero S; Hall B; Kutyifa V; Rao N; Rao N; Goldenberg I
    JACC Clin Electrophysiol; 2024 Jul; 10(7 Pt 1):1468-1476. PubMed ID: 38878014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
    Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
    Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter-defibrillator.
    Abbas H; Younis A; Goldenberg I; McNitt S; Aktas MK; Tabaja C; Ojo A
    J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1203-1211. PubMed ID: 38606650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death with an implantable cardioverter-defibrillator: a MADIT-II substudy.
    Chernomordik F; Jons C; Klein HU; Kutyifa V; Nof E; Zareba W; Daubert JP; Greenberg H; Glikson M; Goldenberg I; Beinart R
    Europace; 2019 Dec; 21(12):1843-1850. PubMed ID: 31647531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease.
    Goldenberg I; Kutyifa V; Zareba W; Huang DT; Rosero SZ; Younis A; Schuger C; Gao A; McNitt S; Polonsky B; Steinberg JS; Goldenberg I; Aktas MK
    Front Cardiovasc Med; 2023; 10():1237118. PubMed ID: 37680559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.